Planned website maintenance is taking place from 11:00 pm AEDT on Friday 30 October to 6:00 am AEDT on Saturday 31 October 2026. Some pages may be temporarily unavailable. If issues continue outside this time, please contact us.

AusPAR: Buprenorphine

Australian Public Assessment Report

AusPAR

AusPAR: Buprenorphine [PDF, 1.23 MB]

AusPAR: Buprenorphine [DOCX, 2.88 MB]

Attachment: Product Information Buprenorphine [PDF, 502.01 KB]

Attachment: Product Information Buprenorphine [DOCX, 624.61 KB]

Attachment: Product Information Buprenorphine 01 [PDF, 503.41 KB]

Attachment: Product Information Buprenorphine 01 [DOCX, 622.33 KB]

Device/Product Name

Buvidal

Active ingredients

Buprenorphine

AusPAR Date

6 November 2019

Published

18 November 2019

Submission Number

PM 2017-02926-1-1

Submission Type

Major variation (new dose form and new dose strengths)

Decision

Approved

Product types

Prescription medicines